When a clinical study is in trouble, the first 30 days decide much of what follows. Effective rescue starts with protecting participants and data, then establishes the facts quickly, stabilizes the most urgent problems, communicates honestly with stakeholders and chooses a path forward based on evidence rather than hope. The most common mistake is changing everything at once before understanding what is actually wrong.
How do you know a study needs rescue?
The signals are usually visible well before anyone uses the word. Enrollment far behind plan with no credible recovery. Sites activating slowly or not at all. Data entry and query backlogs growing. Important deviations rising. Budget overruns and frequent change orders. Turnover on the CRO team. Inspection or audit findings. Sites complaining. A study team that has stopped believing its own forecasts.
What comes first?
Participant safety and data integrity. Confirm that safety reporting is working, that participants are being followed as the protocol requires and that critical data are being collected and protected. Everything else can wait a few days. These cannot.
Week one: what are the facts?
Gather the real status of the study, not the reported status. Review enrollment and screen failures by site, site activation, data status, deviations, safety reporting, budget and spending, open issues and the CRO's staffing. Talk to people: the CRO team, a sample of sites and your own staff. Look for patterns. Are problems concentrated in certain sites, countries or functions? Is the protocol itself driving the trouble?
Weeks two and three: how do you stabilize?
Fix the urgent. Address any safety, data integrity or compliance gaps immediately.
Set up governance. A short-cycle cadence, often weekly, with clear owners and actions.
Clean up communications. One source of truth for status and a single issue log.
Support the sites that matter. Visit or call key sites, resolve payment and supply problems and remove obstacles.
Stop the bleeding on budget. Review pending change orders and spending against the most likely path.
Week four: what path should you choose?
With facts in hand, weigh the options. Recover with the current CRO, with a corrective plan, new commitments and stronger oversight. Amend the protocol if design is the cause. Add sites or countries. Change the CRO or bring specific functions back to the sponsor or a specialty vendor. Pause, redesign or stop. Each path has costs, risks and timelines, and the board deserves an honest comparison.
How should you communicate during rescue?
Honestly and regularly. Tell the board what you know, what you don't know yet and when you will know it. Tell sites what is changing and why. Tell the CRO what you expect and how you will measure it. Over-reassurance in the first weeks erodes trust when the full picture emerges.
Should you change the CRO?
Sometimes, but not reflexively. Transitions take time, cost money and carry their own risks. Changing CROs makes sense when performance problems are deep, leadership is unresponsive and corrective plans have failed. Often, the faster path is a reset with the current CRO, combined with clearer governance and sponsor oversight.
Keep reading: What a Rapid Operational Assessment of a Running Study Reveals
